Form 4 Tracker
Mark A Goldsmith

Director, President and Chief Executive Officer · 5 filings · Latest: Jun 16, 2026

Revolution Medicines, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerJun 16, 2026
Sale
$156.1210,020$1.6M267,330
RVMD
GOLDSMITH MARK AJun 15, 2026
Proposed Sale
$153.879,772$1.5M
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerApr 15, 2026
Sale
$150.09120,000$18.0M276,698
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerApr 15, 2026
Option Exercise
$4.61120,000$552.7K396,698
RVMD
MARK A GOLDSMITHApr 15, 2026
Proposed Sale
$147.01120,000$17.6M
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerMar 17, 2026
Sale
$99.4812,871$1.3M276,698
RVMD
GOLDSMITH MARK AMar 16, 2026
Proposed Sale
$99.5913,261$1.3M
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerMar 2, 2026
Sale
$101.2336,000$3.6M64,424
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerMar 2, 2026
Option Exercise
$4.0930,000$122.7K319,569
RVMD
JONATHAN GOLDSMITH REVOCABLE TRUSTMar 2, 2026
Proposed Sale
$102.023,000$306.1K
RVMD
THE REBECCA GOLDSMITH REVOCABLE TRUSTMar 2, 2026
Proposed Sale
$102.023,000$306.1K
RVMD
MARK A GOLDSMITHMar 2, 2026
Proposed Sale
$102.0230,000$3.1M
RVMD
Mark A GoldsmithDirector, President and Chief Executive OfficerFeb 6, 2026
Option Exercise
$0.5424,010$13.0K256,479
RVMD
GOLDSMITH MARK ADec 15, 2025
Proposed Sale
$77.8114,964$1.2M
RVMD
J H GOLDSMITH & M A GOLDSMITHCO-TTEE JONATHAN GOLDSMITH REV TRU/A/D 8/16/2023Nov 25, 2025
Proposed Sale
$73.663,000$221.0K
RVMD
THE REBECCA GOLDSMITH REVOCABLE TRUSTNov 25, 2025
Proposed Sale
$73.663,000$221.0K
RVMD
MARK A GOLDSMITHNov 25, 2025
Proposed Sale
$73.6660,000$4.4M
RVMD
MARK A GOLDSMITHNov 18, 2025
Proposed Sale
$69.1420,000$1.4M
RVMD
MARK A GOLDSMITHNov 12, 2025
Proposed Sale
$64.0820,000$1.3M
RVMD
MARK A GOLDSMITHNov 7, 2025
Proposed Sale
$61.3830,000$1.8M

Page 1 of 2

Next →